Cord blood LC-PUFA composition and allergic diseases during the first 10 yr. Results from the LISAplus study
Version of Record online: 27 FEB 2014
© 2014 The Authors. Pediatric Allergy and Immunology Published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Pediatric Allergy and Immunology
Volume 25, Issue 4, pages 344–350, June 2014
How to Cite
Cord blood LC-PUFA composition and allergic diseases during the first 10 yr. Results from the LISAplus study. Pediatr Allergy Immunol 2014: 25: 344–350., , , .
- Issue online: 22 JUN 2014
- Version of Record online: 27 FEB 2014
- Manuscript Accepted: 31 JAN 2014
- Federal Ministry for Education, Science, Research, and Technology. Grant Numbers: 01 EG 9732, 01 EG 9705/2, 01 EE 9401-4
- Federal Ministry of Environment. Grant Number: FKZ 20462296
- Commission of the European Communities. Grant Number: FP7/2007-13
- European Research Council. Grant Number: 3226059
Figure S1. Participant flow.
Table S1. Comparison of all investigated variables between study participants and non-participants.
Table S2. Results of a GEE in which n-3, n-6 LC-PUFA concentrations, and n-6/n-3 ratio in cord blood (CB) serum are regressed on allergic diseases restricted to children with complete information on all time points.
Table S3. Results of general linear models in which n-3, n-6 LC-PUFA concentrations, and n-6/n-3 ratio in cord blood (CB) serum are regressed on allergic diseases stratified for each follow-up.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.